Meta-Analysishigh evidence
Short-term effects of combinations of heart failure therapies on blood pressure, kidney function and serum potassium.
Nature medicine·August 31, 2026·PMID 42675244
Why it mattersConcerns about hypotension, renal dysfunction, and hyperkalemia often limit initiation of guideline-directed heart failure therapy. These individualized estimates help clinicians anticipate and manage these effects when combining ARNI, MRAs, and SGLT2 inhibitors.
The papers that matter, first.
MedLit ranks the medical literature into a specialty feed with concise summaries, evidence-aware triage, and visual takeaways.
§
MedLit · Evidence, Distilled